Compared with other colorectal, ovarian, and renal clear cell carcinomas, the mechanism of CPT2 in hepatocellular carcinoma has been relatively well studied, and the studies have placed more emphasis on upstream transcription factors, inhibitors of CPT2, and the effects of combinations of drugs. Here, CPT2 is linked to hepatocellular carcinoma.